Tuesday 20th September 2022 |
Text too small? |
KMD Brands Limited (ASX/NZX: KMD , “KMD” or the “Company”) is pleased to announce its results for the twelve months ended 31 July 2022 (“FY22”).
FY22 key highlights (vs FY21):
• Group sales up 6.2% to $979.8 million, a record for KMD Brands
o Continued growth in Rip Curl sales, highest-ever Kathmandu sales in Q4, and record order demand for Oboz products
• Gross margin maintained at 58.9% despite input cost pressure
• Underlying EBITDA of $92.0 million reflects the impact of Q1 Australasian lockdowns and Oboz supply chain COVID disruption
o Record second half Group sales and underlying EBITDA
• Statutory NPAT of $36.8 million; Underlying NPAT(1) of $36.2 million
• Strong balance sheet position supports investment in organic brand growth
• Final dividend of 3 cents per share (fully franked for Australian shareholders); total FY22 dividend of 6 cents per share represents a record $42.5 million dividends declared in FY22
The following are attached in relation to KMD Brands Limited's Full Year Result for the period to 31 July 2022:
1. Results Announcement
2. Media Announcement
3. Financial Statements and Independent Auditor's Report
4. Investor Presentation
5. Distribution Notice
Investor briefing being held today @ 8:30am AEST / 10:30am NZST
Michael Daly (Group CEO & Managing Director) and Chris Kinraid (Group CFO) will be holding a briefing session for investors and analysts at 8:30am AEST / 10:30am NZST today (Tuesday 20 September). To pre-register and avoid a queue when calling, please follow this link:
https://event.webcasts.com/starthere.jsp?ei=1567475&tp_key=9b518569b6
If you are unable to pre-register, at the time of the call please dial one of the numbers below and provide the Participant Code 648518 to the operator.
Australia Toll Free: 1800 590 693
Australia Local: +61 (0) 2 7250 5438
New Zealand Toll Free: 0800 423 972
New Zealand Local: +64 (0) 9 9133 624
United States: +1 323 794 2558
- ENDS -
No comments yet
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report
RAD - Radius Care Announces On-market Share Buyback Programme
MCY - New wind farm propels MCY renewables commitment to $1b